Replies to post #444943 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Apparently you haven't read the timeline you linked. 7 months after submission of letter of intent before the MAA can be submitted.
Feb'ish is not an option.

[BakedLangostino]

Alzheimer's EMA submission will probably occur sometime between April and July.

Rett FDA submission will probably be sometime in Q3 2024.

Alzheimer's FDA submission will probably be in early 2025, assuming the FDA considers the data from the extension trial that is set to wrap up this summer acceptable for a confirmatory trial. If the FDA requests a proper P3 trial, the NDA could be punted until 2026 -- but at this point we'll know whether Blarcamesine works and the share price should reflect the revenues from Rett and the European Alzheimer's market.

[ExtremelyBullishZig]

They only think an MAA isn't material if they don't hear anything for awhile. That way it fits their narrative. See how that works?...LOL